People · Operator
Named in public records as an officer, director or promoter · active 2020–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Alume Biosciences Inc | — | Biotechnology | Series A | $33.4M | $18.9M | 2020 |
Kim T. Kamdar at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kim T. Kamdar on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Magda Marquet | 1 | 6 |
| Kim Kamdar | 1 | 6 |
| James Schmidt | 1 | 3 |
| Jean-Pierre Millon | 1 | 3 |
| Dan Bradbury | 1 | 3 |
| Brett Berman | 1 | 2 |
| Magda T. Marquet | 1 | 2 |
| Kaveri Parker | 1 | 2 |
| Jean-Pierre T Million | 1 | 1 |
| Quyen Nguyen | 1 | 1 |
| Jean-Pierre T. Millon | 1 | 1 |
| James T. Schmidt | 1 | 1 |
| Quyen T. Nguyen | 1 | 1 |
| Dan T. Bradbury | 1 | 1 |
| Brett T. Berman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.